-
Date: January 6, 2010Roundtable ID: CV0010Citation: Med Roundtable Cardiovasc Ed. ; 1(2): 73 - 78.
Statins: Do They Have Beneficial Effects Over and Above Their Actions on Lipids?
Moderator:
There is no moderator for this particular article.
Discussants:
There are no discussants for this particular article.
-
Summary:
Dr. Antonio Gotto from Weill Cornell Medical College moderated the topic "Statins: Do they have beneficial effects over and above their actions on lipids?" with Drs. John LaRosa from State University of New York-Downstate Medical Center, and James Reiffel from Columbia University Medical Center participating.
- The discussion focused primarily on:
- (1) possible additional benefits, or pleiotropic effects, of statins beyond statin monotherapy's primary effect to reduce LDL cholesterol,
- (2) the results of the clinical trial JUPITER and the use of statins for prevention,
- (3) the use of CRP as a cardiovascular risk factor,
- (4) the increased risk of diabetes balanced against cardiovascular benefits,
- (5) the impact of statins on atrial fibrillation,
- (6) the effectiveness in acute coronary syndrome,
- (7) the antioxidant effects of statins, and
- (8) the use of omega-3 fish oils.
- (Med Roundtable Cardiovasc Ed. 2010;1(2):73-78) ©2010 FoxP2 Media, LLC
-
Compounds:Trials:
4S, AFCAPS/TexCAPS, ALLIANCE, ARMYDA-3, ASCOT LLA, CHS, CTT, GISSI-HF, HPS, IDEAL, JUPITER, LIPID, MIRACL, SEAS, TIMI, TNT
Please subscribe to use our print features or to download PDF files.